Allogeneic Stem Cell-Based Platforms to Potentiate and Deliver Oncolytic Virus Therapies
Time: 9:30 am
day: Day Two
Details:
- Shortcomings of unprotected oncolytic virus therapies
- Advantages of Calidi’s stem cell-based platforms for potentiation of oncolytic virotherapies – preclinical data
- Calidi’s clinical programs
